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Abstract
Few studies have investigated the association between psychotherapeutic approaches
and their processes in routine psychological practice. We compared cognitive therapy
(CT) and behavioral activation (BA) on their effectiveness and change processes.
Forty-three depressed patients participated in our trial. Scores on depression and
specific and nonspecific factors were collected at seven time points and analyzed using
RM-ANOVA and multiple linear regressions. No differences in depression reduction
emerged between conditions. Most processes changed during therapy. Only measures
of negative cognitions and behavioral activation interacted with treatment condition.
Change on the processes did not predict symptom alleviation. Similarly, reductions in
depression were not followed by change on any of the process measures. Both
psychotherapeutic approaches led to significant and comparable symptom reduction.
There was no clear evidence of differential change with respect to purported underlying
mechanisms. The results are discussed in the context of therapy and research.
Keywords Depression . Psychotherapy. Cognitive therapy . Behavioral activation .
Changemechanisms
The high prevalence of depression and the burden it places on the individual and
society has long been recognized (Cuijpers et al. 2007; Fried and Nesse 2014;
Greenberg, Fournier, Sisitsky, Pike, and Kessler 2015; Kessler et al. 2005; Mathers,
Fat, and Boerma 2008; Mehta, Mittal, and Swami 2014; Trivedi 2004). Next to
antidepressant medication (ADM), several psychotherapeutic approaches to the treat-
ment of major depression exist, among which cognitive therapy (CT; Beck 1964) is one
of the most extensively researched (Cuijpers et al., 2013b; Hofmann, Asnaani, Vonk,
Sawyer, and Fang 2012). Evidence has accumulated showing that CT can be as
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effective as ADM (DeRubeis, Gelfand, Tang, and Simons 1999). DeRubeis et al.
(2005) conducted one of the first large trials in which they compared ADM, CT, and
a pill placebo for patients with moderate to severe depression. Their overall results did
not show significant differences between the active conditions at the end of treatment.
However, both outperformed the pill placebo group. A meta-analysis by Cuijpers et al.
(2013a) points in a similar direction. The authors found no significant differences
between CT during the acute phase and continued ADM. This held for both short-
and long-term effects. CT is now recommended as a first line choice in the treatment
guidelines for depression in the Netherlands (Spijker et al. 2013).
The study reported herein is a pragmatic pilot trial that has been conducted as
part of a series of Dutch trials in outpatient settings. Despite the original CT manual
(Beck, Rush, Shaw, and Emery 1979) recommending two weekly sessions in the
beginning of therapy, most therapists in Europe generally see their patients only
once per week (Bruijniks et al. 2015). Therefore, the first aim of this trial was to test
the implementation of a regimen of two psychotherapy sessions per week. Second-
ly, we wanted to inform a large ongoing study described in Bruijniks et al. (2015)
on the effects of session frequency and other mechanism of change in psychother-
apy for depression. Thirdly, we intended to provide a benchmark for the effective-
ness and mechanism trial by Lemmens et al. (2015), which compared one session
per week of CT to interpersonal psychotherapy (IPT). In addition to session
frequency, we investigated specific and nonspecific processes that are believed to
underlie symptom change. To do this, we compared a group of patients receiving
CT to a group receiving behavioral activation (BA), while also measuring factors
presumed to underlie symptom change in depression at multiple time points, in an
attempt to understand how these treatments work. BA was chosen as a comparator
due to its ease of application and renewed interest in the approach (Richards et al.
2016). Earlier research has indicated that BA is as effective as CT (Barth et al. 2013;
Cuijpers, Andersson, Donker, and van Straten 2011; Dimidjian et al. 2006;
Jacobson et al. 1996).
With respect to the purported mechanisms of change, CT posits that resolution
of negative cognitions and schemas leads to improvement (Beck et al. 1979; Butler
and Beck 1995), an assumption that has received considerable validation
(DeRubeis et al. 1990; Renner, Lobbestael, Peeters, Arntz, and Huibers 2012;
Warmerdam, van Straten, Jongsma, Twisk, and Cuijpers 2010). However, it has
been shown that such cognitions co-vary with the disorder (Beevers and Miller
2005; Teasdale 1983). Moreover, though CT places unique importance on negative
thoughts, a reduction in such cognitions seems to accompany most interventions
(Fava, Bless, Otto, Pava, and Rosenbaum 1994; Garratt, Ingram, Rand, and
Sawalani 2007; Kovacs, Rush, Beck, and Hollon 1981), making it difficult to
clearly identify them as the underlying change mechanism. An analysis of the
temporal sequencing of the outcome (e.g., depression) and the potential mecha-
nism or mediator (e.g., negative cognitions) of a specific treatment approach is
necessary (Kraemer, Wilson, Fairburn, and Agras 2002).
In contrast to CT, the BA model proposed by Lewinsohn (1974) makes no
assumption about clients’ thinking patterns. Instead, it presumes a lack in positive
reinforcement as the maintaining factor of depression, and emphasizes the impor-
tance of behavioral activation. Therefore, we assessed this latter factor as well.
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Finally, the therapeutic relationship has long been hypothesized as a nonspecific
driving force in therapy success (Horvath and Symonds 1991; Martin, Garske, and
Davis 2000); we therefore also assessed participants’ perception of the relationship
with their therapist. To our knowledge, this is the first study that directly compared
CT and BA in a Dutch healthcare setting. In this report, we provide the results of the
pragmatic pilot trial.
Method
Design
Participants were recruited from a Dutch outpatient treatment center (Hendriks &
Roosenboom, Arnhem; now Dr. Bosman, Arnhem). They provided informed con-
sent before being included in the study. Inclusion criteria were a diagnosis of
depression based on the results of the Structured Clinical Interview for DSM
Disorders (SCID-I; First, Spitzer, Gibbon, and Williams 2002) and a score above
20 on the Beck Depression Inventory, Second Edition (BDI-II; Beck, Steer, Ball,
and Ranieri 1996). Participants were excluded if they had severe comorbid condi-
tions, such as substance dependence or schizophrenia. Moreover, participants were
also excluded if they had received CT or BAwithin 12 months preceding the study,
were taking antidepressant medication that could not be discontinued, or reported
any level of suicidal ideation. The last criterion was applied due to the specific care
that would be called for, in particular, the need for medication. Since the treatment
center only provides specialist care for anxiety and mood disorders, incoming
patients with (severe) personality or bipolar disorders are always referred else-
where. Eligible patients were allocated to therapists who were in turn randomized
to provide either BA or CT. Although a specified protocol detailing the allocation
procedure to avoid confounding by therapist availability (e.g., more than one
therapist available) was not employed, such confounding is highly unlikely. Thus,
our trial approached quasi-randomization. Following assessment, patients were
registered at the secured online research platform, which was used to collect the
outcome measures at predefined time intervals.
Interventions
We scheduled two therapy sessions per week during the first 8 weeks of the study. The
remaining sessions were held on a weekly basis, the number of which depended on the
progress of the individual patient. Although all therapists underwent formal CT
training, most were relatively inexperienced. To optimize treatment and increase
motivation to participate in this trial, they received additional training. This was
provided in the form of separate two-day courses by two experienced clinicians in
the field of CT and BA (S.D. Hollon and C. Martell). In addition, they received frequent
peer supervision. Though a formal integrity check was not performed, treatment
integrity was monitored by means of weekly peer consultation and occasional video-
conferences with the two trainers. The CTapproach was based on the original treatment
manual developed by Beck and his colleagues (Beck et al. 1979) using adaptations
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described elsewhere (Lemmens et al. 2011). Behavioral components were thus not
specifically excluded in this approach. BA was provided according to the manuals
developed by Martell and colleagues (Martell, Addis, and Jacobson 2001; Martell,
Dimidjian, and Herman-Dunn 2010) as applied in a previous study on the effectiveness
of BA (Moradveisi, Huibers, Renner, Arasteh, and Arntz 2013).
Measurements
Participants completed all measures using the online platform and personal log-in
codes. Following baseline assessment, measures were taken during the active treatment
phase at 4, 8, 12, and 16 weeks. As described before, by week eight most participants
had received 16 therapy sessions. Follow-up measures were taken at weeks 20 and 24.
Dutch translations of the original instruments were used.
Depressive Symptoms Severity of depression was measured using the BDI-II, a 21-
item tool with demonstrable reliability and construct validity for the original and
Dutch version (Beck et al. 1996; Kuhner, Burger, Keller, and Hautzinger 2007;
Nolen and Dingemans 2004). Values on the inventory range from 0 to 63 with
higher scores indicating more severe depressive symptoms. More recent studies
suggest a score below 12 to indicate at most minimal depression or the point of
remission (Riedel et al. 2010).
Negative Cognitions Maladaptive negative beliefs were assessed using two instru-
ments. The 17-item version of the Dysfunctional Attitude Scale (DAS-17; de Graaf,
Roelofs, and Huibers 2009) and the revised version of the Automatic Thought Ques-
tionnaire (ATQ-R; Kendall, Howard, and Hays 1989; Raes and Hermans 2011), The
ATQ-R was used to complement the DAS-17 as a measure of more superficial
cognitions. Higher scores on both instruments refer to more negative cognitions.
Behavioral Activation The Behavioral Activation for Depression Scale (BADS; Kanter,
Mulick, Busch, Berlin, and Martell 2007; Raes, Hoes, Van Gucht, Kanter, and Hermans
2010) consists of four factors, each of which comprises a subscale. The activation
subscale (BADSa, 7 items) measures the degree of activation as perceived by the
patient. Here, higher scores refer to more activation. The avoidance/rumination sub-
scale (BADSar, 8 items) assesses patients’ ruminative and avoidant behaviors with
higher scores relating to more of these instances. The school/work impairment and
social impairment subscales (BADSws and BADSs, each 5 items) examine problems in
the respective areas and higher scores indicate more impairment.
Therapeutic Alliance The therapeutic alliance was examined with the 12-item form of
the patient-rated version of the Working Alliance Inventory (WAI-S-C; Hatcher and
Gillaspy 2006). The instrument incorporates three subscales, each consisting of four
items. These refer to the perceived congruence between therapist and client on (a) the
goals of therapy (WAI-S-Cg), (b) the assumption that the tasks employed in therapy will
aid in problem resolution (WAI-S-Ct), and (c) the quality of the relationship within the
therapeutic dyad (WAI-S-Cb). Higher scores on any subscale indicate a better relation-
ship between practitioner and patient.
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Statistical Analysis
Analyses were conducted at significance level α = .05 and based on the intention-to-
treat (ITT) sample. Approaches that are insensitive to missing data (such as multilevel
modeling) were not feasible in this study due to the size of our sample. Accordingly,
initial attempts to use such analyses failed. In order to enable the use of other analyses,
multiple regression imputation was used to replace incomplete information on the
outcome and process measures. The investigation of missing data revealed no system-
atic pattern, confirming the validity of the application of multiple regression imputa-
tion. Random numbers were generated using the Mersenne Twister option and the
results from a total of five imputations were aggregated to compose the final values. To
preserve the explanatory power of the multiple assessment points, repeated measures
analysis of variance (RM-ANOVA) were employed. BDI-II scores measured at all
seven time points (i.e., including both follow-up assessments) were used as within-
subjects variables to assess the effectiveness of the treatment modalities. Treatment
condition was coded as − .5 for CT and .5 for BA and then added as the between-
subjects variable (as suggested by Kraemer, Kiernan, Essex, and Kupfer 2008). Viola-
tions of sphericity were countered by using the Greenhouse-Geisser correction. Simi-
larly, the change and temporal sequence of each individual process measure over the
course of the treatment phase (baseline to week 16) was subjected to a RM-ANOVA
with treatment condition as between-subjects factor (to assess differential process
change in the two treatment conditions). Significant interactions between time and
treatment condition were further investigated using simple contrasts for differences
between baseline and each following assessment point per condition. Between- and
within-group effect sizes (Cohen’s d) were computed for two time points per condition.
The former were based on the mean scores at the end of the treatment phase (week 16)
and last mean scores at follow-up (week 24). The latter were calculated from the
difference between mean scores at baseline and week 16 and baseline and follow-up at
week 24 (within the CT or BA group) and corrected for correlations between means.
Next, exploratory analyses were conducted to investigate the predictive power of early
change in process measures on later change in depression reduction. To do this, mean
centered change scores from baseline to scores achieved at week 4 were computed for
all process measures to comprise early change on these variables. Late change on
depression was defined as the difference between BDI-II scores at week 4 and the last
assessment during treatment at week 16 (before follow-up). Using multiple linear
regressions, late change in depression was then regressed on early change in process
measures, controlling for baseline BDI-II scores. To investigate differential effects of
BA and CT, treatment condition and its interaction with change on mean centered
process measures was included in the equations. Bonferroni corrections were used to
counter inflation of type-I error rates (i.e., αcorrected .05/10 comparisons = .005). As
outlined before, it is important to assess the direction of change and therefore look at
the temporal sequencing of it (see also Kraemer, Stice, Kazdin, Offord, and Kupfer
2001; Kraemer et al. 2002). To provide a basic analysis of this, vice versa regression
analyses were conducted. Early change in depression severity from baseline to week 4
was regressed on late change in the process variables, i.e., from week 4 to week 16.
Case wise diagnostics with a two standard deviations (sd) criterion were used to
identify potential outliers and analyses were rerun after these were controlled for.
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Results
Participants
In total, 44 patients were eligible for participation. Only one (allocated to BA)
dropped out of the study before the start of the first session. Forty-three participants
were therefore left for assessment (CT = 23, BA = 20). Their age ranged from 19 to
72 with a mean of 39 years (sd = 14.5). Baseline scores on the BDI-II identified
them as a highly depressed sample with mean scores of 30.2 and 32.1 in the CT and
BA group respectively. Randomization proved successful in the equal distribution
of demographic and baseline characteristics of process measures and depression
scores. A slight majority of participants was female (51.2%) and most were of
Dutch origin (95.3%). Table 1 provides an overview of demographic data per
treatment condition. Inconsistent provision of information on depressive symptoms
and processes was substantial, making imputation necessary. In the CT condition,
8.7% of data on all outcome and process measures were missing in week 4, further
increasing to 34.8% in week 8. During weeks 12 to 20, the proportion sunk slightly
to 30.4% only to increase at the last assessment in week 24 to 39.1%. In the BA
condition, 5% of information on the ATQ-R-NL was missing at baseline assess-
ment. For the remaining time points, the proportion was equal for all variables.
From 20% in week 4, progressing to 35% in week 8 and slightly declining to 25%
and 20% in weeks 12 and 16 respectively. At the first follow-up assessment, 35% of
participants did not provide information on outcome measures, though only 30% of
this information was missing at the second follow-up. χ2 tests indicated no
Table 1 Summary of demographic variables per condition
CT (N = 23) BA (N = 20)
Sex (% females) 52.2% 50%
Age (M, sd) 35.3 (12.6) 42.2 (15.9)
Relationship status (N, %)
Single 6 (26.1%) 5 (25%)
Living with family 4 (17.4%) 0 (0%)
Relationship/married 11 (47.8%) 12 (60%)
Divorced 2 (8.7%) 3 (15%)
Education (N, %)
None/elementary 2 (8.7%) 3 (15%)
Secondary 11 (47.8%) 5 (25%)
High-school 9 (39.2%) 11 (55%)
University 1 (4.3%) 1 (5%)
Employment (N, %)
Full-/part-time 10 (43.5%) 7 (35%)
Homemaker 1 (4.3%) 0 (0%)
Student 3 (13.1%) 3 (15%)
Unemployed/retired 9 (39.1%) 10 (50%)
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differences in these percentages between the two conditions at any time point
(all p ≥ .28).
At the end of the study, some patients were still in treatment. In these cases, the
focus of therapy generally shifted towards issues not covered by the initial diagno-
sis of depression. Table 2 depicts a summary of descriptive statistics of depression
and process measures after missing data were imputed. Based on the available data,
the mean number of sessions received over the whole assessment period (i.e.,
including follow-up) was 21.3 (sd = 20.1, N = 19) in the CT condition and 19.6
(sd = 13.7, N = 18) in BA.
Symptom Reduction
The results of the RM-ANOVA showed a significant reduction in depression scores
over time, F(4.4, 179.8) = 39.7, p < .001. However, no differences between condi-
tions emerged, F(4.4, 179.8) = .96, p = .44. The mean score on the BDI-II at the end
of the study treatment phase in week 16 was 18.4 (sd = 11.6) for CT and 20.2
(sd = 10.6) for BA. At the last follow-up assessment in week 24, these scores were
15.4 (sd = 9.1) for participants receiving CT and 14.4 (sd = 7.9) for those in the BA
group. The associated within-groups effect sizes at the last assessment were large
with a Cohen’s d of 1.89 for CT and 1.69 for BA (see Table 2 for all effect sizes).
Figure 1a shows the rate of change on depression scores over the entire course of
the study for both conditions.
Change in Process Measures over Time
The results of the RM-ANOVA showed that all process measures underwent
significant change over time. Change in the direction that indicates improvement
was found for the DAS-17, F(4, 164) = 6.7, p < .001; the BADS total score, F(4,
164) = 11.6, p < .001; the BADS activation subscale, F(4, 164) = 6.0, p < .001; the
WAI-S-C goal subscale, F(3.4, 139.1) = 3.5, p = .01; the WAI-S-C task subscale,
F(4, 164) = 2.4, p = .05; the WAI-S-C bond subscale, F(3.2, 131.2) = 6.5, p < .001;
and scores on the ATQ-R-NL, F(3.1, 128.5) = 12.1, p < .001. Change in a negative
direction (e.g., more ruminative behavior) was found on the BADS avoidance/
rumination subscale, F(4, 164) = 7.3, p < .001; the BADS work/school impairment
subscale, F(2.9, 118.7) = 7.6, p < .001; and the BADS social impairment subscale,
F(3.1, 127.4) = 6.2, p < .001.
Interactions with Treatment
Two significant interactions emerged between treatment condition and time
predicting scores on process measures. One was the DAS-17, F(4, 164) = 2.5,
p = .04: negative cognitions decreased in both conditions, but this change occurred
earlier in BA compared to CT (see also Fig. 1b). This was confirmed by the simple
contrasts comparing change on the DAS-17 from baseline to each subsequent
assessment point. For the CT condition, the planned comparisons became signifi-
cant at week 16 and remained so at both follow-up assessments (all p < .02),
whereas in the BA group, these contrasts were significant throughout the course
International Journal of Cognitive Therapy (2018) 11:343–358 349
of the study (p ≤ .04) and still marginally significant at the second follow-up in
week 24 (p = .06). The second significant interaction was found for the BADS
activation subscale, F(4, 164) = 2.6, p = 0.4: activation increased more steeply in
CT, whereas this was relatively stable in BA (see also Fig. 1c). The simple contrasts
Table 2 Descriptive statistics at baseline end of treatment, and follow-up, as well as within- and between-
groups effect sizes for these time points
Variable and
condition
Baseline Week 16 (end of study treatment phase) Week 24 (follow-up)
M sd M sd dwithin dbetween M sd dwithin dbetween
BDI-II
CT 30.2 8.1 18.3 11.6 1.5 − .17 15.4 9.1 1.89 .12
BA 32.1 11 20.2 10.6 1.04 14.4 7.9 1.69
DAS-17
CT 69.5 18.1 61.1 19.1 0.57 − .01 60.3 22.2 0.54 − .22
BA 73.5 18.6 61.2 17.4 0.76 64.7 16.2 0.45
BADSt
CT 74.9 16 96.1 15 − .95 .56 99.6 19.6 − 1.0 .13
BA 72 18.1 85.7 21.7 − 0.69 97.3 15 − 1.38
BADSa
CT 11.5 4.8 18.5 5.9 − 1.09 .34 20.6 6 − 1.21 .2
BA 14.6 6.5 16.4 6.4 − 0.28 19.4 5.7 − 0.64
BADSar
CT 26.5 8.1 32.9 6 − .59 .54 33.8 7.2 − .62 .28
BA 22.5 8.2 28.8 9 − .92 31.6 8.4 − 1.26
BADSws
CT 19 5 21.1 3.8 − .4 .23 22.4 4.3 − .61 − .24
BA 16.5 6.1 20 5.9 − .58 23.3 2.9 − 1.6
BADSs
CT 17.8 6.2 23.5 3.1 − .87 .7 22.7 4.7 − .72 − .07
BA 18.5 5.5 20.7 4.8 − .32 23 3.1 − 1.12
WAI-S-Cg
CT 10.9 3 12 2.7 − .34 − .31 12.6 1.8 − .77 .14
BA 11.5 1.7 12.7 1.6 − .64 12.3 2.4 − .34
WAI-S-Ct
CT 5.6 1.5 6.4 1.5 − .45 − .08 6.2 1.2 − .38 .00
BA 6.1 1.2 6.5 .9 − .29 6.2 .9 − .08
WAI-S-Cb
CT 17 3.9 19 3.4 − .52 − .36 19.6 2.4 − .74 .45
BA 17.3 2.8 20 1.8 − 1.17 18.6 2 − .41
ATQ-R-NL
CT 103.2 17.7 86.1 19.7 0.74 − .24 80.7 15.5 1.05 − .20
BA 112 22.3 91.4 24.3 1.22 83.8 14.7 1.59
N = 23 (CT), 20 (BA)
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for the BADS activation subscale showed that the planned comparisons from
baseline to each subsequent assessment point were significant throughout all mea-
surement points for CT (all p ≤ .01). In BA, the contrasts were only significant for
the two follow-up measures (all p ≤ .04).
As shown in Table 2, within-group effect sizes of the process measures were
generally moderate to large according to cut-points suggested by Cohen (1988).
Merely, the effect of the WAI-S-C task subscale in week 24 almost disappeared in
the BA condition, confirming the results of the analysis of change over time.
The effect sizes of all measures between the two groups were largely small (see
Table 2). Taking into account the orientation of each instrument (i.e., do higher scores
refer to improvement or impairment), a moderate effect was found on the BADS total
score at week 16 (d = .56), indicating more overall activation in the CT condition at that
point, which is confirmed by the results on the activation subscale at the same time
(d = .34). The effect on the avoidance/rumination subscale (d = .54) shows less of these
instances and therefore more favorable outcomes for the BA condition at week 16, and
Fig. 1 Change for scores on (a) the BDI-II, (b) the DAS-17, and (c) the BADS activation subscale for both
conditions
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the same was true for the social impairment subscale (d = .7). However, both of these
were diminished or disappeared at follow-up. At week 24, one moderate effect emerged
on the WAI-S-C bond scale (d = .45), indicating a better relationship between patient
and therapist in the CT condition. This effect reversed from the time of the last
assessment during the study treatment phase in week 16 (d = − .36).
Prediction of Late Change in Depression
Early change on process measures was not predictive of late change in depression for
any of the variables. This was true even before Bonferroni corrections were applied (all
p > .36). Removing two outliers (one from each treatment condition, identical cases for
all measures) did not significantly change these results. Moreover, treatment condition
and its interaction with early change on each process measure did not predict late
change in depression (all p > .11). Similar results were obtained when vice versa
regressions were conducted in order to predict late change in process measures from
early change in BDI-II scores (all p > .34).
Discussion
Main Findings
We observed significant reductions over time on the BDI-II as a measure of
depression in both conditions (although in the absence of differences relative to
any control condition we cannot rule out the occurrence of spontaneous remission).
At the end of the study, many participants still evidenced residual complaints and
were still in treatment, which suggest that patients in routine settings need more and
continued treatment to recover from depression. There was no statistically signif-
icant difference in BDI-II scores between the CT and BA group. Although this is in
line with meta-analytic evidence (Barth et al. 2013; Cuijpers et al., 2013b), the
twice-weekly session frequency could have led to an accelerated symptom reduc-
tion, distinguishing the effects from other studies that used different or similar
frequency regimens. In this regard, the study presented herein served as a bench-
mark for the randomized controlled trial by Lemmens et al. (2015). We observed
similar reductions in depression scores during a shorter period of time using twice-
weekly sessions compared to the weekly sessions of either CT or IPT in the trial by
Lemmens et al. (2015).
Despite the promising results for the early stages of treatment, they should be
considered with caution. In their seminal randomized controlled trial, Dimidjian et al.
(2006) compared the effects of CT, BA, and ADM for the treatment of depression.
They found that for the highly depressed participants, BA outperformed CT. Moreover,
on average, their participants experienced a reduction of around 13 points on the BDI-II
in the CT and around 20 in the BA condition during the early therapy phase, therefore
significantly exceeding the reductions found in our trial. A potential reason could be
different levels of therapist experience and skill between the trials. Moreover, adher-
ence to the treatment manual could not be monitored continuously since there was no
formal integrity check.
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Process Measures
All processes that were hypothesized to be associated with symptom improvement
changed over the course of treatment but mostly in a manner independent of treatment
modality. It is conceivable that these processes were influenced directly by the rela-
tively early changes in symptomatology and could therefore not be reliably distin-
guished as mechanisms of treatment.
Only negative cognitions measured by the DAS-17 and behavioral activation by the
respective BADS subscale interacted significantly with treatment condition in the RM-
ANOVA, pointing to a differential change path in BA and CT. However, as shown in
Fig. 1b, the effect on the DAS-17 was largely a consequence of a sudden drop in
maladaptive cognitions during the initial phase of BA. The post-hoc contrasts con-
firmed this relatively early reduction on negative cognitions in the BA group. This
association is not what would have been predicted by cognitive theory. However, as
Lorenzo-Luaces, German, and DeRubeis (2014) suggest in their extensive review,
noncognitive interventions can produce changes in cognitions. This therefore does
not disqualify cognitive change as a potential process underlying symptom reduction.
In addition, depression is a complicated condition that involves a web of intertwined
behavioral and cognitive factors. However, as is also shown in the figure, a comparable
amount of change occurred on the DAS-17 in the CT condition at a later stage. Thus,
the two treatment modalities were associated with comparable change in the DAS-17
over time, with the bulk of the observed change in BA happening over the first half of
the study and the bulk of the change in CT happening over the second half. These
findings are in line with previous research, showing that maladaptive thinking patterns
“wax and wane” with the condition (Beevers and Miller 2005). Similarly, overall
behavioral activation measured by the BADS activation subscale increased more in
the CT group, as indicated by the RM ANOVA and effect sizes. This finding seems to
counter the theoretical underpinnings of BA. Though the reasons for this are unknown,
it is noteworthy that the CT approach did not specifically exclude behavioral tech-
niques. In addition, cognitive restructuring techniques can lead to behavioral change. A
general increase in activity was therefore not surprising.
An unexpected finding was the fact that most of the other constructs measured by
the BADS changed significantly, but in a way that represents more problems in areas
such as work, school, or other social contexts, and an increase in avoidant and
ruminative behavior. Relatively more issues in the social domain were experienced
by patients in the CT group. One explanation for this could be that they reported a
larger increase in overall behavioral activation. More specifically, withdrawal from
social situations has long been noted as a concurrent symptom in depression (Heinrich
and Gullone 2006). Breaking through this containment is therefore certainly an uneasy
process. In addition, healthy individuals often react rather negatively to depressed
persons and their behavior (Sacco and Vaughan 2006), making the step out of the
isolation even more difficult and confronting. The perception of an increase in prob-
lems in the social domain for patients in the CT group could therefore be explained by
the fact that they encountered social situations more often. However, the between-
groups effects on the BADS avoidance/rumination, work/school and social impairment
subscales were either diminished or near zero at the follow-up assessment, showing that
negative outcomes of such confrontation are not necessarily persistent.
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The moderate effect size associated with the bond between therapist and patients
suggests that at week 16, patients in the BA condition rate the quality of the relationship
relatively better compared to those receiving CT but that this effect is reversed at
follow-up. One possible interpretation is that the intensive consideration of thoughts
and feedback by the therapist in CT increased the connection with the patient in the
long term. On the other hand, the behavioral approach, using more applied exercises
together with the therapist, could have enhanced the rating of the quality of the dyad
particularly during the active treatment phase of the study, relative to the CT condition.
Moreover, the bond between patient and therapist has been considered as a result of
symptom improvement, rather than a mechanism in itself (Webb et al. 2011). The
moderate size of the effect of this relationship at follow-up could therefore be a
retrospection of some patients (as many of them did not receive treatment anymore at
this point) that was the more positively evaluated, the better treatment outcomes were.
However, as outlined before, others were still in therapy at this last assessment. For
these patients, the WAI-S-Cb was a more valid measure of the bond with the therapist.
Strengths and Limitations
There were several limitations to this study that we tried to counter as far as this was
possible. Although the design we used prevented us from drawing causal inferences, the
finding that several of the processes that we observed (all derived from theory) did change
in the predicted direction simultaneously with symptom change has an exploratory value.
Moreover, the allocation procedure we used approximated quasi-randomization, an ap-
propriate approach in this routine care setting. To counter usual criticisms of such
pragmatic contexts, we specifically targeted and reduced the potential for the provision
of lower quality therapy in effectiveness compared to efficacy trials. We did so by assuring
good training and supervision by experts, as well as frequent peer meetings, although a
formal integrity check was not performed. Despite these precautions, we cannot state that
the level of therapists’ experience was equivalent to the strict requirements normally
applied in efficacy studies. Finally, the small sample size we recruited affects the infer-
ences drawn. Attempts to implement more complex multilevel approaches for effective-
ness and mediation analyses failed due to unsatisfactory model fit. However, the number
of participants is a general issue in clinical research and our sample falls within a range
comparable to some other studies (e.g., Troeung, Egan, and Gasson 2014; Weiss et al.
2012) and the chosen statistical approach is a sophisticated alternative in this context.
Finally, missing data is often problematic and this trial suffered from a high degree of it.
We used the best possible analytic approach in this situation, namely multiple imputation.
Although analyses indicated no differences between the two conditions on the percentage
of missing data, this does not mean that this is not a major concern. The results need to be
interpreted with caution, as the imputation may have inflated results.
Conclusion
Both CT and BA led to significant reductions in depressive symptomatology that was
comparable to other studies and there is basic evidence that increasing the session
frequency can have beneficial effects when compared to a benchmark trial. Moreover,
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the comparable effectiveness of the BA and CTapproaches adds to the literature, which
finds BA to be potentially more easy to implement and more cost effective (Gilbody
et al., 2017; Richards et al. 2016). However, there was no clear evidence of differential
change with respect to purported underlying mechanisms. Although negative cogni-
tions showed a time-lagged decrease in favor of BA, other analyses did not indicate
differential change in the two conditions. The same was true for perceived activation
(i.e., measured by the BADS activation subscale). That could have been the case if the
respective theories are correct even in the absence of differences in outcomes between
the treatment conditions. The overall finding that problems in the social domain as
measured by the respective BADS subscales (i.e., avoidance/rumination, work/school,
and social impairment) increased instead of decreased over the course of the study
could be a result of overall activation.
To our knowledge, this is the first time a study on the comparison between both
modalities employed multiple assessments of process measures in a pragmatic
sample in routine practice. However, a limitation of this study is the relatively
small sample we recruited, and we encourage other researchers to replicate our
approach with a larger sample.
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